GlassScriptPhysician profile
Dallas Christopher Smith
NPI 1699065243
$17,433.96
in general payments reported to CMS, 2019-2025
41 companies · $4,300 in 2025
The $4,300 reported for 2025 was more than what 90% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,327 · 2020: $956 · 2021: $1,713 · 2022: $1,384 · 2023: $2,053 · 2024: $4,700 · 2025: $4,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,636 · Travel and Lodging: $1,863 · Consulting Fee: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,635.79 |
| Travel and Lodging | $1,862.85 |
| Consulting Fee | $555.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $5,613.88 | 2023-2025 | Prospera, Biotronik |
| Boston Scientific Corporation | $3,129.13 | 2019-2025 | Na, Click, Avista Mri |
| Medtronic USA, INC. | $1,632.12 | 2019-2020 | |
| Nalu Medical, INC. | $1,364.29 | 2021-2025 | Nalu Neurostimulation System |
| Abbvie INC. | $937.03 | 2021-2025 | Ubrelvy, Qulipta |
| Nevro Corp. | $881.57 | 2019-2024 | Senza |
| Vertiflex, INC. | $526.95 | 2019 | |
| Spinal Elements, INC. | $452.36 | 2024-2025 | |
| Medtronic, INC. | $423.25 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Nuvasive, INC. | $360.39 | 2019-2023 | Xlif |
| Vertos Medical, INC. | $306.49 | 2023-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $286.97 | 2019-2025 | Relistor |
| Painteq LLC | $282.49 | 2022-2024 | Painteq |
| Collegium Pharmaceutical, INC. | $171.83 | 2020-2023 | Xtampza, Belbuca |
| Stryker Corporation | $158.31 | 2024 | Mild Device Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dallas Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.